Comparison of Pathadarvyadi churna vati with Tablet metformin and only tablet metformin in the treatment of diebetes Mellitus(Type 2)
Phase 1
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2019/04/018471
- Lead Sponsor
- Prinipal PDEAs college of Ayurveda and Research centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Age group between 35 years to 65 years.
2 Cases of both Gender will be included.
3 Patient with fasting blood sugar upto 200 mg% and post prandial blood sugar upto 300 mg%
Exclusion Criteria
1.Insulin Dependent Diabetes Mellitus (IDDM)
and those who are under insulin therapy.
2.Patients with acute complications like Hyperglycemic & hypoglycemic coma, Ketoacidosis and related complication and Infections like gangrene.
3.Patients with chronic diabetic complications like Nephropathy, Neuropathy and
Retinopathy.
4. Pregnant & lactating women.
5. Patients suffering from all major systemic diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate efficacy of PathaDarvyadi Churna Vati 500 mg two times before meal a day for 3 months as an adjuvant medication to Metformin 500 mg in the management of Prameha with special reference to Diabetes Mellitus type 2 on the basis of BSL and HbA1c values <br/ ><br> <br/ ><br>Timepoint: 90 days with follow up on every 15th day <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1 to study the effect of pathadarvyadi churna vati <br/ ><br>2 to study the effect of metformin <br/ ><br>3 to observe the adverse effect if anyTimepoint: 90 days